Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Human TRIB2 is a repressor of FOXO that contributes to the malignant phenotype of melanoma cells

Abstract

FOXO transcription factors are evolutionarily conserved proteins that orchestrate gene expression programs known to control a variety of cellular processes such as cell cycle, apoptosis, DNA repair and protection from oxidative stress. As the abrogation of FOXO function is a key feature of many tumor cells, regulation of FOXO factors is receiving increasing attention in cancer research. In order to discover genes involved in the regulation of FOXO activity, we performed a large-scale RNA-mediated interference (RNAi) screen using cell-based reporter systems that monitor transcriptional activity and subcellular localization of FOXO. We identified genes previously implicated in phosphoinositide 3-kinase/Akt signaling events, which are known to be important for FOXO function. In addition, we discovered a previously unrecognized FOXO-repressor function of TRIB2, the mammalian homolog of the Drosophila gene tribbles. A cancer-profiling array revealed specific overexpression of TRIB2 in malignant melanoma, but not in other types of skin cancer. We provide experimental evidence that TRIB2 transcript levels correlate with the degree of cytoplasmic localization of FOXO3a. Moreover, we show that TRIB2 is important in the maintenance of the oncogenic properties of melanoma cells, as its silencing reduces cell proliferation, colony formation and wound healing. Tumor growth was also substantially reduced upon RNAi-mediated TRIB2 knockdown in an in vivo melanoma xenograft model. Our studies suggest that TRIB2 provides the melanoma cells with growth and survival advantages through the abrogation of FOXO function. Altogether, our results show the potential of large-scale cell-based RNAi screens to identify promising diagnostic markers and therapeutic targets.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6

Similar content being viewed by others

References

  • Berns K, Hijmans EM, Mullenders J, Brummelkamp TR, Velds A, Heimerikx M et al. (2004). A large-scale RNAi screen in human cells identifies new components of the p53 pathway. Nature 428: 431–437.

    Article  CAS  Google Scholar 

  • Birmingham A, Anderson EM, Reynolds A, Ilsley-Tyree D, Leake D, Fedorov Y et al. (2006). 3′ UTR seed matches, but not overall identity, are associated with RNAi off-targets. Nat Methods 3: 199–204.

    Article  CAS  Google Scholar 

  • Brunet A, Bonni A, Zigmond MJ, Lin MZ, Juo P, Hu LS et al. (1999). Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor. Cell 96: 857–868.

    Article  CAS  Google Scholar 

  • Calnan DR, Brunet A . (2008). The FoxO code. Oncogene 27: 2276–2288.

    Article  CAS  Google Scholar 

  • Dansen TB, Burgering BM . (2008). Unravelling the tumor-suppressive functions of FOXO proteins. Trends Cell Biol 18: 421–429.

    Article  CAS  Google Scholar 

  • Gomes AR, Brosens JJ, Lam EW . (2008). Resist or die: FOXO transcription factors determine the cellular response to chemotherapy. Cell Cycle 7: 3133–3136.

    Article  CAS  Google Scholar 

  • Grosshans J, Wieschaus E . (2000). A genetic link between morphogenesis and cell division during formation of the ventral furrow in Drosophila. Cell 101: 523–531.

    Article  CAS  Google Scholar 

  • Gupta PB, Kuperwasser C, Brunet JP, Ramaswamy S, Kuo WL, Gray JW et al. (2005). The melanocyte differentiation program predisposes to metastasis after neoplastic transformation. Nat Genet 37: 1047–1054.

    Article  CAS  Google Scholar 

  • Hegedus Z, Czibula A, Kiss-Toth E . (2006). Tribbles: novel regulators of cell function; evolutionary aspects. Cell Mol Life Sci 63: 1632–1641.

    Article  CAS  Google Scholar 

  • Hegedus Z, Czibula A, Kiss-Toth E . (2007). Tribbles: a family of kinase-like proteins with potent signalling regulatory function. Cell Signal 19: 238–250.

    Article  CAS  Google Scholar 

  • Hellemans J, Mortier G, De Paepe A, Speleman F, Vandesompele J . (2007). qBase relative quantification framework and software for management and automated analysis of real-time quantitative PCR data. Genome Biol 8: R19.

    Article  Google Scholar 

  • Hilmi C, Larribere L, Deckert M, Rocchi S, Giuliano S, Bille K et al. (2008). Involvement of FKHRL1 in melanoma cell survival and death. Pigment Cell Melanoma Res 21: 139–146.

    Article  CAS  Google Scholar 

  • Hou L, Panthier JJ, Arnheiter H . (2000). Signaling and transcriptional regulation in the neural crest-derived melanocyte lineage: interactions between KIT and MITF. Development 127: 5379–5389.

    CAS  PubMed  Google Scholar 

  • Hu MC, Lee DF, Xia W, Golfman LS, Ou-Yang F, Yang JY et al. (2004). IkappaB kinase promotes tumorigenesis through inhibition of forkhead FOXO3a. Cell 117: 225–237.

    Article  CAS  Google Scholar 

  • Huang H, Tindall DJ . (2007). Dynamic FoxO transcription factors. J Cell Sci 120: 2479–2487.

    Article  CAS  Google Scholar 

  • Hui RC, Francis RE, Guest SK, Costa JR, Gomes AR, Myatt SS et al (2008). Doxorubicin activates FOXO3a to induce the expression of multidrug resistance gene ABCB1 (MDR1) in K562 leukemic cells. Mol Cancer Ther 7: 670–678.

    Article  CAS  Google Scholar 

  • Keeshan K, He Y, Wouters BJ, Shestova O, Xu L, Sai H et al (2006). Tribbles homolog 2 inactivates C/EBPalpha and causes acute myelogenous leukemia. Cancer Cell 10: 401–411.

    Article  CAS  Google Scholar 

  • Mata J, Curado S, Ephrussi A, Rorth P . (2000). Tribbles coordinates mitosis and morphogenesis in Drosophila by regulating string/CDC25 proteolysis. Cell 101: 511–522.

    Article  CAS  Google Scholar 

  • Meier F, Busch S, Lasithiotakis K, Kulms D, Garbe C, Maczey E et al (2007). Combined targeting of MAPK and AKT signalling pathways is a promising strategy for melanoma treatment. Br J Dermatol 156: 1204–1213.

    Article  CAS  Google Scholar 

  • Myatt SS, Lam EW . (2007). The emerging roles of forkhead box (Fox) proteins in cancer. Nat Rev Cancer 7: 847–859.

    Article  CAS  Google Scholar 

  • Paik JH, Kollipara R, Chu G, Ji H, Xiao Y, Ding Z et al (2007). FoxOs are lineage-restricted redundant tumor suppressors and regulate endothelial cell homeostasis. Cell 128: 309–323.

    Article  CAS  Google Scholar 

  • Rosado A, Zanella F, Garcia B, Carnero A, Link W . (2008). A dual-color fluorescence-based platform to identify selective inhibitors of Akt signaling. PLoS ONE 3: e1823.

    Article  Google Scholar 

  • Segura MF, Hanniford D, Menendez S, Reavie L, Zou X, Alvarez-Diaz S et al (2009). Aberrant miR-182 expression promotes melanoma metastasis by repressing FOXO3 and microphthalmia-associated transcription factor. Proc Natl Acad Sci USA 106: 1814–1819.

    Article  CAS  Google Scholar 

  • Soengas MS, Lowe SW . (2003). Apoptosis and melanoma chemoresistance. Oncogene 22: 3138–3151.

    Article  CAS  Google Scholar 

  • Yang H, Zhao R, Yang HY, Lee MH . (2005). Constitutively active FOXO4 inhibits Akt activity, regulates p27 Kip1 stability, and suppresses HER2-mediated tumorigenicity. Oncogene 24: 1924–1935.

    Article  CAS  Google Scholar 

  • Zanella F, Rosado A, Blanco F, Henderson BR, Carnero A, Link W . (2007). An HTS approach to screen for antagonists of the nuclear export machinery using high content cell-based assays. Assay Drug Dev Technol 5: 333–341.

    Article  CAS  Google Scholar 

  • Zanella F, Rosado A, Garcia B, Carnero A, Link W . (2008). Chemical genetic analysis of FOXO nuclear-cytoplasmic shuttling by using image-based cell screening. Chembiochem 9: 2229–2237.

    Article  CAS  Google Scholar 

  • Zanella F, Rosado A, Garcia B, Carnero A, Link W . (2009). Using multiplexed regulation of luciferase activity and GFP translocation to screen for FOXO modulators. BMC Cell Biol 10: 14.

    Article  Google Scholar 

Download references

Acknowledgements

This work was supported by a grant from the Spanish MEC (project BIO2006-02432). FZ is the recipient of a Marie Curie Fellowship. We acknowledge the expert technical assistance of D Megias, J C Cigudosa, J Monsech and O Dominguez. We thank M Hu, T Unterman and E Kiss-Toth for providing plasmids and JF Martinez for helpful discussions and critical reading of this paper. We are indebted to R Bernards for advice and for providing us with the NKI shRNA library.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to W Link.

Ethics declarations

Competing interests

The authors declare no conflict of interest.

Additional information

Supplementary Information accompanies the paper on the Oncogene website

Supplementary information

Rights and permissions

Reprints and permissions

About this article

Cite this article

Zanella, F., Renner, O., García, B. et al. Human TRIB2 is a repressor of FOXO that contributes to the malignant phenotype of melanoma cells. Oncogene 29, 2973–2982 (2010). https://doi.org/10.1038/onc.2010.58

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/onc.2010.58

Keywords

This article is cited by

Search

Quick links